NASDAQ:CPTS - Bayer Essure Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started Previous CloseN/AToday's RangeN/A52-Week RangeN/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileDiscussionChartEarningsFinancialsInsider TradesHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Conceptus, Inc. designs, develops, markets and promotes solutions in women's healthcare. The Company's flagship product is the Essure permanent birth control procedure, which is the non-surgical permanent birth control system. The Essure delivers a soft and flexible insert into a woman's fallopian tubes, causing a benign tissue in-growth, which blocks the fallopian tubes. Successfully placed Essure inserts and the subsequent tissue growth around, and through the inserts prohibits the egg from traveling through the fallopian tube, preventing conception. In October 2011, the Company acquired from its Dutch distributor certain assets and all distribution rights of the Essure device. In October 2011, it purchased certain assets of Sigma Medical and established a wholly owned subsidiary in the Netherlands, Conceptus B.V. (BV). During the year ended December 31, 2011, approximately 600,000 women worldwide have undergone the Essure procedure. Receive CPTS News and Ratings via Email Sign-up to receive the latest news and ratings for CPTS and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry N/A Sub-IndustryHealth Care Equipment SectorN/A Current SymbolNASDAQ:CPTS Previous Symbol CUSIP20601610 CIK896778 Webwww.conceptus.com Phone+1-302-6365400Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable Bayer Essure (NASDAQ:CPTS) Frequently Asked Questions What is Bayer Essure's stock symbol? Bayer Essure trades on the NASDAQ under the ticker symbol "CPTS." Has Bayer Essure been receiving favorable news coverage? Media stories about CPTS stock have been trending somewhat positive this week, InfoTrie Sentiment reports. The research group scores the sentiment of news coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Bayer Essure earned a daily sentiment score of 2.0 on InfoTrie's scale. They also assigned press coverage about the healthcare company a news buzz of 8.0 out of 10, meaning that recent news coverage is very likely to have an impact on the company's share price in the near term. How do I buy shares of Bayer Essure? Shares of CPTS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Bayer Essure's official website? The official website for Bayer Essure is http://www.conceptus.com/. How can I contact Bayer Essure? Bayer Essure's mailing address is 100 Bayer Rd, PITTSBURGH, PA 15205-9707, United States. The healthcare company can be reached via phone at +1-302-6365400. MarketBeat Community Rating for Bayer Essure (NASDAQ CPTS)Community Ranking: 2.9 out of 5 ( )Outperform Votes: 116 (Vote Outperform)Underperform Votes: 87 (Vote Underperform)Total Votes: 203MarketBeat's community ratings are surveys of what our community members think about Bayer Essure and other stocks. Vote "Outperform" if you believe CPTS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CPTS will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 3/19/2019 by MarketBeat.com StaffFeatured Article: What is a Derivative?